Are patients with primary glomerular disease at increased risk of malignancy?

被引:2
|
作者
Han, Jialin [1 ]
Zhao, Yinshan [2 ]
Canney, Mark [3 ,4 ]
Atiquzzaman, Mohammad [1 ]
Keown, Paul [1 ]
Levin, Adeera [1 ,5 ]
Barbour, Sean [1 ,5 ]
机构
[1] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[4] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Prov Hlth Serv Author, BC Renal, Vancouver, BC, Canada
关键词
cancer; ESRD; glomerulonephritis; immunosuppression; kidney transplantation; CANCER INCIDENCE; SYSTEMIC-LUPUS; RHEUMATOID-ARTHRITIS; LYMPHOMA RISK; SKIN-CANCER; ASSOCIATION; THERAPY; METAANALYSIS; EXPOSURE; GLOMERULONEPHRITIS;
D O I
10.1093/ndt/gfad261
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Over the past decade, several observational studies and case series have provided evidence suggesting a connection between glomerular diseases and the development of malignancies, with an estimated risk ranging from 5 to 11%. These malignancies include solid organ tumours as well as haematologic malignancies such as lymphoma and leukaemia. However, these risk estimates are subject to several sources of bias, including unmeasured confounding from inadequate exploration of risk factors, inclusion of glomerular disease cases that were potentially secondary to an underlying malignancy, misclassification of glomerular disease type and ascertainment bias arising from an increased likelihood of physician encounters compared with the general population. Consequently, population-based studies that accurately evaluate the cancer risk in glomerular disease populations are lacking. While it is speculated that long-term use of immunosuppressive medications and glomerular disease activity measured by proteinuria and estimated glomerular filtration rate may be associated with cancer risk in patients with glomerular disease, the independent role of these risk factors remains largely unknown. The presence of these knowledge gaps could lead to a lack of awareness of cancer as a potential chronic complication of glomerular disease, underutilization of routine screening practices in clinical care that allow early diagnosis and treatment of malignancies and underrecognition of modifiable risk factors to decrease the risk of de novo malignancies over time. This review summarizes the current evidence on the risk of cancer in patients with glomerular diseases, explores the limitations of prior studies and discusses methodological challenges and potential solutions for obtaining accurate estimates of cancer risk and identifying modifiable risk factors unique to GN populations. 10.1093/ndt/gfad261 Video Watch the video of this contribution at https://academic.oup.com/ndt/pages/author_videos gfad261Media1 6344835995112
引用
收藏
页码:910 / 919
页数:10
相关论文
共 50 条
  • [31] Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study
    Joshi, Utsav
    Bhattarai, Adheesh
    Gaire, Suman
    Gill, Simrat
    Agrawal, Vishakha
    Yadav, Sumeet Kumar
    Low, Soon Khai
    Dhakal, Prajwal
    Bhatt, Vijaya Raj
    Kouides, Peter A.
    LEUKEMIA & LYMPHOMA, 2022, 63 (14) : 3456 - 3461
  • [33] Risk of malignancy in Korean patients with primary Sjogren's syndrome
    Kang, Juyeon
    Kim, Hyoungyoung
    Kim, Jinwook
    Choi, Seongmi
    Jung, Sun-Young
    Jang, Eun Jin
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (09) : 1240 - 1247
  • [34] ARE PATIENTS TREATED WITH TNF ANTAGONISTS FOR PSORIASIS AT INCREASED RISK FOR INFECTION AND MALIGNANCY?
    Dommasch, E. D.
    Abuabara, K.
    Shin, D. B.
    Nguyen, J.
    Troxel, A. B.
    Gelfand, J. M.
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2011, 3 (05) : 302 - 303
  • [35] Increased Risk of Renal Malignancy in Patients with Moderate to Severe Atopic Dermatitis
    Oh, Jongwook
    Oh, Hyun Ju
    Han, Kyung-Do
    Gee, Heon Yung
    Lee, Ji Hyun
    CANCERS, 2023, 15 (20)
  • [36] INCREASED RISK OF MALIGNANCY AND BLOOD-MEMBRANE INTERACTIONS IN UREMIC PATIENTS
    AKIZAWA, T
    KINUGASA, E
    KOSHIKAWA, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 : 162 - 164
  • [38] USE OF BIOLOGICS DOES NOT INCREASE THE RISK OF MALIGNANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
    Afraz, Sadaf
    Gonzalez, Adalberto
    Tandon, Kanwarpreet S.
    Kamjani, Milad Heydari
    Alomari, Mohammad
    Rashid, Mamoon
    Castro, Fernando
    GASTROENTEROLOGY, 2022, 162 (07) : S789 - S790
  • [39] Increased Risk of Second Primary Malignancy in Pediatric and Young Adult Patients Treated with Radioactive Iodine for Differentiated Thyroid Cancer
    Marti, Jennifer L.
    Jain, Kunal S.
    Morris, Luc G. T.
    THYROID, 2015, 25 (06) : 681 - 687
  • [40] Lenalidomide and risk of second primary malignancy-is disease context key?
    Pawlyn, Charlotte
    Bird, Sarah
    LANCET HAEMATOLOGY, 2022, 9 (12): : E868 - E869